| Theme | Current Topics on The Treatment for Esophageal Cancer | |
|---|---|---|
| Title | Surgery for m3•m1 Esophageal Cancer: Treatment Strategy Based on the Analysis of Lymph Node Metastasis | |
| Publish Date | 2003/10 | |
| Author | Yoshiaki Kajiyama | Department of Surgery Juntendo University, School of Medicine |
| Author | Masahiko Tsurumaru | Department of Surgery Juntendo University, School of Medicine |
| Author | Yoshimi Iwanuma | Department of Surgery Juntendo University, School of Medicine |
| Author | Natsumi Tomita | Department of Surgery Juntendo University, School of Medicine |
| Author | Takayuki Amano | Department of Surgery Juntendo University, School of Medicine |
| [ Summary ] | The rate of lymph node metastasis in m3•sm1 esophageal cancer was almost 20%. Metastatic lymph nodes in m3•sm1 esophageal cancer were frequently found both along the recurrent laryngeal nerve and around the gastric cardia, as well as in advanced esophageal cancer. The pathologic diameters of metastasis in the lymph nodes of esophageal cancer cases were less than 5mm in almost two thirds of all metastatic nodes. Preoperative diagnosis of lymph node metastasis is not possible with 100% precision. Currently the most reliable method of treatment for m3•sm1 esophageal cancer is esophagectomy, with precise lymph node dissection. The number of lymph node metastasis in the m3•m1 range with esophageal cancer was low, and we can cure these esophageal cancers with accurate lymph node dissection, resulting in a low rate of postoperative morbidity and mortality. In the treatment of m3•sm1 esophageal cancer, quality assurance for surgical procedures is essential. |
|